370 related articles for article (PubMed ID: 29082727)
21. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
22. Defective
Freeman CD; Hansen T; Urbauer R; Wilkinson BJ; Singh VK; Hines KM
mSphere; 2024 Jun; 9(6):e0011524. PubMed ID: 38752757
[TBL] [Abstract][Full Text] [Related]
23. Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate.
Murthy MH; Olson ME; Wickert RW; Fey PD; Jalali Z
J Med Microbiol; 2008 Aug; 57(Pt 8):1036-1038. PubMed ID: 18628509
[TBL] [Abstract][Full Text] [Related]
24. Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia.
Chen CJ; Huang YC; Chiu CH
J Antimicrob Chemother; 2015 Nov; 70(11):2965-72. PubMed ID: 26216581
[TBL] [Abstract][Full Text] [Related]
25. Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.
Yang SJ; Mishra NN; Kang KM; Lee GY; Park JH; Bayer AS
Microb Drug Resist; 2018 Oct; 24(8):1075-1081. PubMed ID: 29381428
[TBL] [Abstract][Full Text] [Related]
26. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
French GL
J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
[TBL] [Abstract][Full Text] [Related]
27. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
28. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
[TBL] [Abstract][Full Text] [Related]
29. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
Cui L; Tominaga E; Neoh HM; Hiramatsu K
Antimicrob Agents Chemother; 2006 Mar; 50(3):1079-82. PubMed ID: 16495273
[TBL] [Abstract][Full Text] [Related]
30. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
[TBL] [Abstract][Full Text] [Related]
31. The use of daptomycin for Staphylococcus aureus infections in critical care medicine.
Alder J
Crit Care Clin; 2008 Apr; 24(2):349-63, ix-x. PubMed ID: 18361950
[TBL] [Abstract][Full Text] [Related]
32. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus.
Peleg AY; Miyakis S; Ward DV; Earl AM; Rubio A; Cameron DR; Pillai S; Moellering RC; Eliopoulos GM
PLoS One; 2012; 7(1):e28316. PubMed ID: 22238576
[TBL] [Abstract][Full Text] [Related]
33. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
34. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.
Hair PI; Keam SJ
Drugs; 2007; 67(10):1483-512. PubMed ID: 17600394
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.
Moise PA; North D; Steenbergen JN; Sakoulas G
Lancet Infect Dis; 2009 Oct; 9(10):617-24. PubMed ID: 19778764
[TBL] [Abstract][Full Text] [Related]
36. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding.
Jones T; Yeaman MR; Sakoulas G; Yang SJ; Proctor RA; Sahl HG; Schrenzel J; Xiong YQ; Bayer AS
Antimicrob Agents Chemother; 2008 Jan; 52(1):269-78. PubMed ID: 17954690
[TBL] [Abstract][Full Text] [Related]
37. Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus
Barros EM; Martin MJ; Selleck EM; Lebreton F; Sampaio JLM; Gilmore MS
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397055
[TBL] [Abstract][Full Text] [Related]
38. [The second life of daptomycin: analysis of a successful come-back].
Decousser JW; Doucet Populaire F
Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
[No Abstract] [Full Text] [Related]
39. Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
Rubio A; Conrad M; Haselbeck RJ; G C K; Brown-Driver V; Finn J; Silverman JA
Antimicrob Agents Chemother; 2011 Jan; 55(1):364-7. PubMed ID: 20974866
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
